Erdosteine-13C4

Erdosteine-13C4

• UNSPSC Description: Erdosteine-13C4 is a 13C-labeled Erdosteine. Erdosteine inhibits lipopolysaccharide (LPS)-induced NF-κB activation[1][2]. Erdosteine has muco-modulatory, anti-bacterial, anti-inflammatory and anti-oxidant effects[3].
• Target Antigen: Bacterial; Isotope-Labeled Compounds; NF-κB
• Type: Isotope-Labeled Compounds
• Related Pathways: Anti-infection;NF-κB;Others
• Field of Research: Infection; Metabolic Disease; Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/erdosteine-13c4.html
• Solubility: 10 mM in DMSO
• Smiles: O=[13C](O)[13CH2]S[13CH2][13C](NC(CCS1)C1=O)=O
• Molecular Weight: 253.28
• References & Citations: [1]Park JS, et al. Anti-inflammatory Effect of Erdosteine in Lipopolysaccharide-Stimulated RAW 264.7 Cells. Inflammation. 2016 Aug;39(4):1573-81.;Oktar S, et al. Beneficial effect of erdosteine on methotrexate-induced testicular toxicity in mice. Toxicol Ind|[2]Oktar S, et al. Beneficial effect of erdosteine on methotrexate-induced testicular toxicity in mice. Toxicol Ind Health. 2010 Aug;26(7):433-8.|[3]Park JS, et al. Anti-inflammatory Effect of Erdosteine in Lipopolysaccharide-Stimulated RAW 264.7 Cells. Inflammation. 2016 Aug;39(4):1573-81.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported